New Treatments for Patients Who Need Them
Processa Pharmaceuticals develops products that improve survival and quality of life for patients with unmet medical needs. Our management and development teams have a track record of obtaining FDA approvals and creating significant shareholder value by successfully delivering much needed therapies to patients and caregivers.
Our portfolio of candidates is disease agnostic and all programs must meet strict evaluation criteria for further development including (but not limited to): representing an unmet medical need; have demonstrated clinical evidence of efficacy; that our Regulatory Science approach can make a difference in the time, cost and risk to obtaining marketing authorization and thus are highly capital efficient and contributes to substantial returns on equity.
